Beatriz Bellosillo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

Journal: European urology oncology
Published: May 05, 2026

Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

Journal: Blood advances
Published: April 08, 2026

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Journal: Cancers
Published: January 26, 2026

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

Journal: Leukemia
Published: January 23, 2026

Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.

Next generation sequencing of circulating tumor DNA for precision medicine in patients with advanced biliary tract cancers.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2026

Response to the letter to the editor entitled "The precision of a report on precision".

Response to the letter to the editor entitled "The precision of a report on precision".

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: December 25, 2025

Gene Fusions in Non-small cell lung carcinoma (NSCLC): Expert Perspectives and Practical Considerations for routine testing.

Gene Fusions in Non-small cell lung carcinoma (NSCLC): Expert Perspectives and Practical Considerations for routine testing.

Journal: Critical reviews in oncology/hematology
Published: December 23, 2025

Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancer.

Expert recommendations for PIK3CA testing in HR+/HER2- locally advanced and metastatic breast cancer.

Journal: NPJ breast cancer
Published: October 30, 2025

Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia.

Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia.

Journal: HemaSphere
Published: September 04, 2025

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells.

Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells.

Journal: The Journal of investigative dermatology
Published: August 05, 2025

Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC).

Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC).

Journal: HemaSphere
Published: May 06, 2025

Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.

Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.

Journal: Virchows Archiv : an international journal of pathology
Published: April 30, 2025
Showing 1-12 of 175

Last Updated: 09/26/2026